CIITA and MHC class II deficiency: Five children (13.9%) were identified with a defect in MHC class II expression—bare lymphocyte syndrome (BLS), and this was accounted for by variants in CIITA (n = 3), RFXANK (n = 1), and RFX5 (n = 1).